Terminal Illness Clinical Trial
— ADJUSTOfficial title:
Study of Advice and Decision-making on Prognosis Using the Judge-advisor System Within Multi-disciplinary Teams (ADJUST)
Verified date | September 2021 |
Source | University College, London |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study investigates how clinicians form intuitive judgements about the prognoses of palliative care patients after receiving advice perceived as coming from either a team member or an algorithm.
Status | Completed |
Enrollment | 323 |
Est. completion date | April 13, 2021 |
Est. primary completion date | April 13, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Clinicians working in an adult palliative care service - Willing and able to provide written informed consent Exclusion Criteria: - None |
Country | Name | City | State |
---|---|---|---|
United Kingdom | University College London | London |
Lead Sponsor | Collaborator |
---|---|
University College, London |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Probability of survival estimate | Clinicians' estimates of the probability of a patient surviving for two weeks (0-100%) | Participants will have up to 7 months (until the study closes) to provide an estimate for each vignette | |
Secondary | Participants' weighting policies (characteristics of the participants) | Participants' responses to demographic questions | Participants will have up to 7 months (until the study closes) to provide an estimate for each vignette | |
Secondary | Participants' weighting policies (the advice itself) | Strength of the prognostic advice provided by the advisor (0-100%) | Participants will have up to 7 months (until the study closes) to provide an estimate for each vignette |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04078815 -
End-of-life Practices in 2019 vs. 2014
|
||
Recruiting |
NCT04750395 -
Comparing Haloperidol and Olanzapine in Treating Terminal Delirium
|
Phase 2 | |
Recruiting |
NCT06108375 -
Differences in Acceptability of Music Therapy Sessions Played Live Compared to a Recording Thereof
|
N/A | |
Completed |
NCT04030910 -
'LIFEView' Audiovisual Technology: Virtual Travel to Support Wellbeing and Quality of Life at the End of Life
|
N/A | |
Completed |
NCT03520270 -
Prevalence of Potentially Inappropriate Treatments
|
||
Enrolling by invitation |
NCT05625854 -
Using a Fan With Aromatherapy in Breathlessness Patients in Terminal Illness
|
N/A | |
Recruiting |
NCT04257227 -
Transcranial Magnetic Stimulation for Psychological Distress in Patients With Advanced Illness
|
N/A | |
Completed |
NCT04678310 -
iLIVE Volunteer Study
|
||
Completed |
NCT04456647 -
Parenteral Nutrition Therapy in Patients With Incurable Cancer
|
||
Completed |
NCT02362295 -
Prospective National Survey of the Palliative Situation Among Inmates in French Prisons
|
N/A | |
Terminated |
NCT03886753 -
Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products
|
||
Active, not recruiting |
NCT04950608 -
Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care
|
Phase 2 | |
Completed |
NCT03336489 -
Evaluation of the Organization of Continuity of Care for Home Hospice Patients by Four Parisian Health Networks
|
||
Completed |
NCT03392857 -
End Of Life in the Critically Ill patiEnt
|
||
Completed |
NCT03697213 -
The Surprise Study
|
||
Completed |
NCT01367613 -
Open-Label Treatment Extension of Protocol MNTX 302
|
Phase 3 | |
Recruiting |
NCT04612738 -
Project Talk Trial: Engaging Underserved Communities in End-of-life Conversations
|
N/A | |
Completed |
NCT02067572 -
A Randomized Controlled Trial Evaluating the Effectiveness of a Salvia-based Mouthwash in Palliative Care
|
N/A | |
Withdrawn |
NCT03041571 -
Impact of Early Implementation of Narrative Medicine Techniques on Patient Centered Attitudes of Medical Students
|
||
Terminated |
NCT03616639 -
Neurotoxic Adverse Effects of Morphine and Oxycodone for Pain in Terminal Patients With Diminished Renal Function
|
Phase 4 |